Posted on 12/06/2012
Speaking to the Daily Mail, regarding the research into developing a treatment for the crippling disease, Duchenne Muscular Dystrophy (DMD), Dr Keith Foster, a scientist specialising in gene therapy from the School of Biological Sciences at Royal Holloway, University of London, said:
‘Most of the funding for research into this [DMD] comes from people rattling tins on our behalf.’
‘The fact is we have the technology to tackle this devastating disease, but we don’t have the funding we need to do it quickly.
‘These patients and their parents are facing a ticking clock. The best hope for these boys is to treat them quickly before their muscles are damaged too badly, so we need to act.
‘We have a real treatment here that might extend life by 40 years, and the cost of developing these molecule patches is relatively small. We can’t afford not to treat these children.
'The Government has to look at its research funding and start shifting its priorities to gene therapies. It’s spending billions on antibiotics, many of which people don’t really need now.’
Click here to read the full story.
Dr Foster was also recently on BBC Radio 5 live, discussing his research into DMD. You can listen here. Dr Foster speaks from 11 minutes 40 seconds to 28 minutes of the 2 hour show.